Injective INJ
Current Price
$3.22 +1.67%
$0.1900 Daily Range (5.90%)
$3.15$3.34
$47.27M Daily Volume
675 BTC
Vol/MktCap: 14.72%
Market Performance
0.09% Relative BTC Volume
The total volume of Injective is $47.27M over the past 24 hours, compared to $52.10B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.27 -1.51%
13 SMA $3.28 -1.82%
21 SMA $3.25 -0.93%
55 SMA $3.21 +0.43%
144 SMA $3.42 -5.76%
Price Performance
-0.43% 1 Hour Change
$3.22 from $3.23
-11.80% 7 Day Change
-$0.3800 from $3.60
-27.73% 14 Day Change
-$0.8930 from $4.11
-37.41% 30 Day Change
-$1.20 from $4.42
All Time High
March 14, 2024
$52.62 -93.86%
-$49.39 vs. now
24H Change
4.89M USD +1.55%
70 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
14.57M INJ
traded over past 24 hours
14.57% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $3.28, reflecting a modest 24-hour change of 0.89%. The daily trading range has been tight, with a high of $3.34 and a low of $3.15, indicating limited volatility in recent sessions.
Volume stands at 56,125,000, which constitutes 17.12% of the market cap, suggesting active trading participation. The short-term moving averages show a mixed sentiment, with the 8-hour SMA at $3.29 indicating a slight downward trend, while the 13-hour and 21-hour SMAs show positive momentum.
The 1-hour RSI is at 67, indicating that INJ is approaching overbought territory, which could imply a short-term pullback. In contrast, the 7-day RSI at 47 suggests a more neutral stance over a longer timeframe, reflecting a lack of strong buying or selling pressure.
From a longer-term perspective, INJ has faced significant price declines, with a 7-day change of -9.83%, a 14-day change of -28.00%, and a 30-day decline of -36.82%. This sustained downtrend emphasizes the need for caution, as the market sentiment remains bearish over these periods.
Injective's all-time high of $52.62, reached in March 2024, underscores the potential upside; however, the current price reflects a substantial retracement from this level. Given the recent performance and technical indicators, the asset shows potential for short-term gains, but long-term weakness cannot be overlooked.
In conclusion, I rate INJ as a Hold. While there may be opportunities for short-term trading given the current price action, the overall trend remains bearish, and caution is advised for longer-term positions.
Volume stands at 56,125,000, which constitutes 17.12% of the market cap, suggesting active trading participation. The short-term moving averages show a mixed sentiment, with the 8-hour SMA at $3.29 indicating a slight downward trend, while the 13-hour and 21-hour SMAs show positive momentum.
The 1-hour RSI is at 67, indicating that INJ is approaching overbought territory, which could imply a short-term pullback. In contrast, the 7-day RSI at 47 suggests a more neutral stance over a longer timeframe, reflecting a lack of strong buying or selling pressure.
From a longer-term perspective, INJ has faced significant price declines, with a 7-day change of -9.83%, a 14-day change of -28.00%, and a 30-day decline of -36.82%. This sustained downtrend emphasizes the need for caution, as the market sentiment remains bearish over these periods.
Injective's all-time high of $52.62, reached in March 2024, underscores the potential upside; however, the current price reflects a substantial retracement from this level. Given the recent performance and technical indicators, the asset shows potential for short-term gains, but long-term weakness cannot be overlooked.
In conclusion, I rate INJ as a Hold. While there may be opportunities for short-term trading given the current price action, the overall trend remains bearish, and caution is advised for longer-term positions.
Updated 554 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Uniswap rebounds: Can UNI push past $4.2 EMA resistance?
Uniswap bounced back from $2.8 slip, climbing to a local high of $3.5.

Forget A Bitcoin Yearly Top, BTC Price Might Have Hit A 16-Year Cyclical Peak
Crypto expert Tony Severino has opined that Bitcoin isn’t just showing signs of a yearly top but also that the BTC price may have hit a 16-year cyclical peak.

Can Solana Price Still Reach A New ATH After Crashing To 2-Year Lows?
Market expert Umair Crypto has released an updated technical analysis on the Solana price from last week.

XRP Price Returns Above $1.5 — On-Chain Data Says Whales Are Behind It
The XRP price was on the verge of losing the $1 level merely two days ago, as the entire crypto market succumbed to an almost unprecedented level of volatility and bearish…